First Time Loading...
F

Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363

Watchlist Manager
Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
Watchlist
Price: 3.29 CNY -4.91% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one Fujian Aonong Biological Technology Group Incorporation Ltd stock under the Base Case scenario is 21.8 CNY. Compared to the current market price of 3.29 CNY, Fujian Aonong Biological Technology Group Incorporation Ltd is Undervalued by 85%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
21.8 CNY
Undervaluation 85%
Relative Value
Price
F
Worst Case
Base Case
Best Case

Valuation Multiples

0.1
P/S
P/S
Price to Sales
0.1
vs History
98
vs Industry
90
Median 3Y
0.5
Median 5Y
0.6
Industry
1
Forward
0.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-6.7
Median 5Y
-1.8
Industry
17.9
Forward
-3.4
More Details
2.2
P/OCF
P/OCF
Price to OCF
2.2
vs History
98
vs Industry
65
Median 3Y
10.8
Median 5Y
20.3
Industry
10
More Details
9.7
P/FCFE
P/FCFE
Price to FCFE
9.7
vs History
31
vs Industry
39
Median 3Y
-9.1
Median 5Y
-17.5
Industry
18.4
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
92
vs Industry
22
Median 3Y
4.5
Median 5Y
4.9
Industry
1.6
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
98
vs Industry
73
Median 3Y
0.8
Median 5Y
1.1
Industry
1.1
Forward
0.4
More Details
135.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
135.4
vs History
17
vs Industry
2
Median 3Y
14
Median 5Y
11.5
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-6.6
Industry
10.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-6.6
Industry
14.6
More Details
7.3
EV/OCF
EV/OCF
Enterprise Value to OCF
7.3
vs History
98
vs Industry
48
Median 3Y
19.4
Median 5Y
30.8
Industry
11.3
More Details
17
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
17
vs History
17
vs Industry
27
Median 3Y
-5.6
Median 5Y
-9.9
Industry
16.2
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
98
vs Industry
62
Median 3Y
1.2
Median 5Y
1.4
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Fujian Aonong Biological Technology Group Incorporation Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
2.8B CNY 0.1 -1.6 -6.4 -6.4
US
Archer-Daniels-Midland Co
NYSE:ADM
30.2B USD 0.3 9.9 8.5 11
CY
Ros Agro PLC
LSE:AGRO
24B USD 7.9 47.1 38.7 51.4
US
Bunge Ltd
NYSE:BG
14.9B USD 0.2 6.6 4.3 4.9
SG
Wilmar International Ltd
SGX:F34
19.9B SGD 0.2 9.7 4 6.1
CN
Tongwei Co Ltd
SSE:600438
99.1B CNY 0.7 4.9 3.4 3.4
US
Ingredion Inc
NYSE:INGR
7.5B USD 0.9 11.7 7.8 9.6
US
Darling Ingredients Inc
NYSE:DAR
6.9B USD 1 10.7 10.1 18.6
MY
Sime Darby Plantation Bhd
KLSE:SIMEPLT
30.6B MYR 1.7 16.5 7.8 11.6
CN
New Hope Liuhe Co Ltd
SZSE:000876
40.7B CNY 0.3 -14.9 -59 -59
ID
Charoen Pokphand Indonesia Tbk PT
IDX:CPIN
86.5T IDR 1.4 35.8 23.4 23.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.